Lord, Abbett & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $19.4M | Buy |
|
|||||
|
2022
Q1 | $22.8M | Buy |
|
|||||
|
2021
Q4 | $26.4M | Sell |
|
|||||
|
2021
Q3 | $38.8M | Buy |
|
|||||
|
2021
Q2 | $34.8M | Sell |
|
|||||
|
2021
Q1 | $43M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $20.9M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $11.2M | Sell |
|
|||||
|
2016
Q2 | $16.5M | Buy |
|
|||||
|
2016
Q1 | $9.87M | Sell |
|
|||||
|
2015
Q4 | $31.4M | Buy |
|
|||||
|
2015
Q3 | $22.3M | Sell |
|
|||||
|
2015
Q2 | $74.5M | Buy |
|
|||||
|
2015
Q1 | $39M | Buy |
|
|||||
|
2014
Q4 | $18.8M | Sell |
|
|||||
|
2014
Q3 | $32.7M | Buy |
|
|||||
|
2014
Q2 | $10.4M | Buy |
|
|||||
|
2014
Q1 | $2.65M | Buy |
|